| - GRCh37:
- Chr12:2800269-2800270
- GRCh38:
- Chr12:2691103-2691104
| CACNA1C, CACNA1C-AS1 | | Timothy syndrome | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr12:2791799
- GRCh38:
- Chr12:2682633
| CACNA1C, CACNA1C-AS1 | H1832R, H1840R, H1843R, H1849R, H1851R, H1860R, H1862R, H1863R, H1871R, H1878R, H1884R, H1891R, H1903R, H1926R | Timothy syndrome | Uncertain significance (May 6, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr12:2622154
- GRCh38:
- Chr12:2512988
| CACNA1C | | Timothy syndrome | Uncertain significance (Mar 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:2690788
- GRCh38:
- Chr12:2581622
| CACNA1C | S640F | Timothy syndrome | Pathogenic (Sep 29, 2022) | no assertion criteria provided |
| - GRCh37:
- Chr12:2763708
- GRCh38:
- Chr12:2654542
| CACNA1C | | Brugada syndrome 3, Long qt syndrome 8, Timothy syndrome
| Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr12:2786377
- GRCh38:
- Chr12:2677211
| CACNA1C, CACNA1C-AS1 | L1638P, L1646P, L1649P, L1655P, L1657P, L1666P, L1668P, L1669P, L1677P, L1690P, L1697P | Timothy syndrome | Uncertain significance (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:2743500
- GRCh38:
- Chr12:2634334
| CACNA1C | L1289W, L1309W, L1317W, L1337W | Timothy syndrome | Uncertain significance (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:2676918
- GRCh38:
- Chr12:2567752
| CACNA1C | V615G, V618G | Timothy syndrome | Pathogenic (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:2558259
- GRCh38:
- Chr12:2449093
| CACNA1C | D199N | Timothy syndrome | Pathogenic (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:2783809
- GRCh38:
- Chr12:2674643
| CACNA1C | | not provided, Cardiovascular phenotype, Brugada syndrome 3, Long qt syndrome 8, Timothy syndrome | Uncertain significance (Mar 31, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2558200
- GRCh38:
- Chr12:2449034
| CACNA1C | I179T | not provided, Brugada syndrome 3, Long qt syndrome 8, Timothy syndrome | Uncertain significance (Aug 9, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2786884
- GRCh38:
- Chr12:2677718
| CACNA1C, CACNA1C-AS1 | | Long qt syndrome 8, Timothy syndrome, Brugada syndrome 3, Long QT syndrome | Likely benign (Sep 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2800230
- GRCh38:
- Chr12:2691064
| CACNA1C, CACNA1C-AS1 | | Long QT syndrome, Timothy syndrome, Brugada syndrome 3, Long qt syndrome 8 | Likely benign (Aug 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2797815
- GRCh38:
- Chr12:2688649
| CACNA1C, CACNA1C-AS1 | A1985V, A2015V, A2037V, A2044V, A1993V, A1996V, A2002V, A2004V, A2024V, A2031V, A2056V, A2013V, A2016V, A2079V | Long qt syndrome 8, Timothy syndrome, Brugada syndrome 3, Long QT syndrome | Uncertain significance (Sep 3, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2783764
- GRCh38:
- Chr12:2674598
| CACNA1C | R1595Q, R1643Q, R1584Q, R1601Q, R1612Q, R1615Q, R1603Q, R1614Q, R1636Q, R1592Q, R1623Q | Long QT syndrome, Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures, Long qt syndrome 8, Brugada syndrome 3, Timothy syndrome | Uncertain significance (Aug 14, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2775883
- GRCh38:
- Chr12:2666717
| CACNA1C | L1509V, L1507V, L1537V, L1568V, L1517V, L1520V, L1540V, L1542V, L1548V | Timothy syndrome, Brugada syndrome 3, Long qt syndrome 8, Long QT syndrome | Uncertain significance (Jun 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2162741
- GRCh38:
- Chr12:2053575
| CACNA1C | N5H | Long QT syndrome, Brugada syndrome 3, Long qt syndrome 8, Timothy syndrome, Cardiovascular phenotype | Uncertain significance (Mar 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2797680
- GRCh38:
- Chr12:2688514
| CACNA1C, CACNA1C-AS1 | P1959R, P1970R, P1971R, P1979R, P1999R, P2034R, P1940R, P1951R, P1957R, P2011R, P1992R, P1948R, P1968R, P1986R | Brugada syndrome 3, Timothy syndrome, Long qt syndrome 8, Long QT syndrome | Uncertain significance (Sep 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2694631
- GRCh38:
- Chr12:2585465
| CACNA1C | T807M, T810M | Cardiovascular phenotype, Timothy syndrome, Brugada syndrome 3, Long qt syndrome 8, Long QT syndrome | Uncertain significance (Sep 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2774139
- GRCh38:
- Chr12:2664973
| CACNA1C | M1509V, M1448V, M1450V, M1481V, M1458V, M1461V, M1483V, M1489V, M1478V | Cardiovascular phenotype, Brugada syndrome 3, Timothy syndrome, Long qt syndrome 8, Long QT syndrome | Uncertain significance (Jul 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2558247
- GRCh38:
- Chr12:2449081
| CACNA1C | W195R | Timothy syndrome | Uncertain significance (Feb 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:2791220
- GRCh38:
- Chr12:2682054
| CACNA1C, CACNA1C-AS1 | R1850K, R1898K | Timothy syndrome | Uncertain significance (May 25, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr12:2694651
- GRCh38:
- Chr12:2585485
| CACNA1C | A815fs, A818fs | Timothy syndrome | Likely pathogenic (Aug 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr12:2789546
- GRCh38:
- Chr12:2680380
| CACNA1C, CACNA1C-AS1 | M1810R | Timothy syndrome | Uncertain significance (Apr 13, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr12:2788627
- GRCh38:
- Chr12:2679461
| CACNA1C, CACNA1C-AS1 | F1692L, F1700L, F1703L, F1709L, F1711L, F1720L, F1722L, F1723L, F1731L, F1744L, F1751L | Timothy syndrome | Uncertain significance (Aug 6, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr12:2717820
- GRCh38:
- Chr12:2608654
| CACNA1C | V1164A, V1167A, V1187A | not provided, Timothy syndrome | Pathogenic/Likely pathogenic (Jun 21, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2622141
- GRCh38:
- Chr12:2512975
| CACNA1C | P458A, P461A | Brugada syndrome 3, Long qt syndrome 8, Timothy syndrome, not provided | Uncertain significance (Aug 27, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2719725
- GRCh38:
- Chr12:2610559
| CACNA1C | A1190T, A1193T, A1213T | Brugada syndrome 3, Long qt syndrome 8, Timothy syndrome, not provided | Uncertain significance (Sep 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2702484
- GRCh38:
- Chr12:2593318
| CACNA1C | A876V, A879V | not provided, Timothy syndrome, Long qt syndrome 8, Brugada syndrome 3 | Uncertain significance (Nov 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2717780
- GRCh38:
- Chr12:2608614
| CACNA1C | A1151T, A1154T, A1174T | Long QT syndrome, Timothy syndrome, Cardiovascular phenotype
| Uncertain significance (Mar 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2714857
- GRCh38:
- Chr12:2605691
| CACNA1C | C1018R, C1021R, C1041R | Long QT syndrome, Timothy syndrome, not provided
| Conflicting interpretations of pathogenicity (Jul 24, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr12:2760966
- GRCh38:
- Chr12:2651800
| CACNA1C | | Timothy syndrome, not provided | Benign (Jul 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2763013
- GRCh38:
- Chr12:2653847
| CACNA1C | V1350L, V1352L, V1360L, V1363L, V1380L, V1383L, V1385L, V1391L, V1411L | Timothy syndrome | Pathogenic (May 13, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr12:2786288
- GRCh38:
- Chr12:2677122
| CACNA1C, CACNA1C-AS1 | | Long qt syndrome 8, Timothy syndrome, Brugada syndrome 3, Cardiovascular phenotype, Long QT syndrome | Likely benign (Apr 28, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2224625
- GRCh38:
- Chr12:2115459
| CACNA1C | | Long qt syndrome 8, Timothy syndrome, Brugada syndrome 3, Cardiovascular phenotype, Long QT syndrome | Likely benign (May 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2602465
- GRCh38:
- Chr12:2493299
| CACNA1C | | Brugada syndrome 3, Timothy syndrome, Long qt syndrome 8, Long QT syndrome | Conflicting interpretations of pathogenicity (Jul 12, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr12:2797846
- GRCh38:
- Chr12:2688680
| CACNA1C, CACNA1C-AS1 | S2023R, S2041R, S2003R, S2025R, S2026R, S2047R, S2054R, S2006R, S2034R, S2066R, S2089R, S1995R, S2012R, S2014R | Brugada syndrome 3, Timothy syndrome, Long qt syndrome 8, Long QT syndrome | Uncertain significance (Jul 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2690777
- GRCh38:
- Chr12:2581611
| CACNA1C | | Long QT syndrome, Timothy syndrome | Conflicting interpretations of pathogenicity (Jun 29, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr12:2602380
- GRCh38:
- Chr12:2493214
| CACNA1C | S311F, S314F | Long QT syndrome, Timothy syndrome, Long qt syndrome 8, Brugada syndrome 3 | Uncertain significance (Aug 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2714893
- GRCh38:
- Chr12:2605727
| CACNA1C | V1030M, V1033M, V1053M | Long QT syndrome, Timothy syndrome, Long qt syndrome 8, Brugada syndrome 3 | Uncertain significance (Jul 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2224422
- GRCh38:
- Chr12:2115256
| CACNA1C | A28T | Long QT syndrome, Timothy syndrome, Long qt syndrome 8, Brugada syndrome 3, Cardiovascular phenotype | Conflicting interpretations of pathogenicity (Sep 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr12:2795008
- GRCh38:
- Chr12:2685842
| CACNA1C, CACNA1C-AS1 | G1883S, G1891S, G1894S, G1900S, G1902S, G1911S, G1913S, G1914S, G1922S, G1929S, G1935S, G1942S, G1954S, G1977S | Timothy syndrome, Long qt syndrome 8, Brugada syndrome 3, Long QT syndrome | Uncertain significance (Mar 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2676851
- GRCh38:
- Chr12:2567685
| CACNA1C | V593M, V596M | Timothy syndrome, Long qt syndrome 8, Brugada syndrome 3, Cardiovascular phenotype, Long QT syndrome | Uncertain significance (Dec 11, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2797919
- GRCh38:
- Chr12:2688753
| CACNA1C, CACNA1C-AS1 | G2020S, G2028S, G2031S, G2037S, G2039S, G2048S, G2050S, G2051S, G2059S, G2066S, G2072S, G2079S, G2091S, G2114S | Timothy syndrome, Long qt syndrome 8, Brugada syndrome 3, Cardiovascular phenotype, Long QT syndrome | Uncertain significance (Apr 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2774784
- GRCh38:
- Chr12:2665618
| CACNA1C | F1466S, F1468S, F1476S, F1479S, F1496S, F1499S, F1501S, F1507S, F1527S | Timothy syndrome, Brugada syndrome 3, Long qt syndrome 8
| Uncertain significance (Dec 18, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr12:2566837
- GRCh38:
- Chr12:2457671
| CACNA1C | V241A | Timothy syndrome, Brugada syndrome 3 | Likely pathogenic (Mar 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr12:2797722
- GRCh38:
- Chr12:2688556
| CACNA1C, CACNA1C-AS1 | P1962L, P2025L, P1954L, P1971L, P1982L, P1993L, P2048L, P1973L, P1984L, P2000L, P2006L, P2013L, P1965L, P1985L | Long QT syndrome, Timothy syndrome, Long qt syndrome 8, Brugada syndrome 3 | Uncertain significance (Oct 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2614116
- GRCh38:
- Chr12:2504950
| CACNA1C | | Timothy syndrome | Uncertain significance (Jan 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr12:2675602
- GRCh38:
- Chr12:2566436
| CACNA1C | R508Q, R505Q | Timothy syndrome, Long QT syndrome | Uncertain significance (Aug 31, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2800276
- GRCh38:
- Chr12:2691110
| CACNA1C, CACNA1C-AS1 | G2099C, G2110C, G2118C, G2151C, G2158C, G2107C, G2116C, G2127C, G2138C, G2145C, G2193C, G2129C, G2130C, G2170C | Long QT syndrome, Timothy syndrome | Uncertain significance (Aug 31, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2797728
- GRCh38:
- Chr12:2688562
| CACNA1C, CACNA1C-AS1 | Q1956R, Q1964R, Q2050R, Q1967R, Q1995R, Q2002R, Q1973R, Q1975R, Q1984R, Q2027R, Q1986R, Q1987R, Q2008R, Q2015R | Timothy syndrome, Long qt syndrome 8, Brugada syndrome 3, Long QT syndrome | Uncertain significance (Jul 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2795439
- GRCh38:
- Chr12:2686273
| CACNA1C, CACNA1C-AS1 | | Timothy syndrome, Brugada syndrome 3, Long qt syndrome 8, Long QT syndrome | Uncertain significance (Mar 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2774047
- GRCh38:
- Chr12:2664881
| CACNA1C | K1430T, K1447T, K1450T, K1458T, K1478T, K1417T, K1419T, K1427T, K1452T | Timothy syndrome | Uncertain significance (May 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr12:2602552
- GRCh38:
- Chr12:2493386
| CACNA1C | W368*, W371* | Timothy syndrome | Likely pathogenic (May 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr12:2224442
- GRCh38:
- Chr12:2115276
| CACNA1C | | Timothy syndrome, Brugada syndrome 3, Long qt syndrome 8, Cardiovascular phenotype, Long QT syndrome | Likely benign (Oct 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2719934
- GRCh38:
- Chr12:2610768
| CACNA1C | | Timothy syndrome, Long QT syndrome, not provided
| Benign (Jul 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2715687
- GRCh38:
- Chr12:2606521
| CACNA1C | | Long QT syndrome, Timothy syndrome, not provided
| Benign (Jul 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2659045
- GRCh38:
- Chr12:2549879
| CACNA1C | | Timothy syndrome, Long QT syndrome | Benign (Jul 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2791754-2791756
- GRCh38:
- Chr12:2682588-2682590
| CACNA1C, CACNA1C-AS1 | E1827del, E1830del, E1858del, E1878del, E1819del, E1847del, E1849del, E1913del, E1850del, E1865del, E1836del, E1838del, E1871del, E1890del | Long QT syndrome, Timothy syndrome | Uncertain significance (Sep 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2705356
- GRCh38:
- Chr12:2596190
| CACNA1C | | not provided, Long QT syndrome, Timothy syndrome
| Benign (Jul 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2795255
- GRCh38:
- Chr12:2686089
| CACNA1C, CACNA1C-AS1 | | not provided, Long QT syndrome, Timothy syndrome
| Benign (Jul 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2783476
- GRCh38:
- Chr12:2674310
| CACNA1C | | Long QT syndrome, Timothy syndrome, not provided
| Benign (Jul 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2757782
- GRCh38:
- Chr12:2648616
| CACNA1C | | not provided, Long QT syndrome, Timothy syndrome
| Benign (Jul 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2757769
- GRCh38:
- Chr12:2648603
| CACNA1C | | not provided, Long QT syndrome, Timothy syndrome
| Benign (Jul 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2757756
- GRCh38:
- Chr12:2648590
| CACNA1C | | not provided, Timothy syndrome, Long QT syndrome
| Benign (Jul 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2720988
- GRCh38:
- Chr12:2611822
| CACNA1C | | not provided, Timothy syndrome, Long QT syndrome
| Benign (Jul 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2706720
- GRCh38:
- Chr12:2597554
| CACNA1C | | not provided, Timothy syndrome, Long QT syndrome
| Benign (Jul 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2690702
- GRCh38:
- Chr12:2581536
| CACNA1C | | not provided, Timothy syndrome, Long QT syndrome
| Benign (Jul 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2676683
- GRCh38:
- Chr12:2567517
| CACNA1C | | not provided, Timothy syndrome, Long QT syndrome
| Benign (Jul 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2613521
- GRCh38:
- Chr12:2504355
| CACNA1C | | not provided, Timothy syndrome, Long QT syndrome
| Benign (Jul 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2760708
- GRCh38:
- Chr12:2651542
| CACNA1C | | Timothy syndrome, not provided | Benign (Jul 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2760970
- GRCh38:
- Chr12:2651804
| CACNA1C | | Timothy syndrome, not provided | Benign (Jul 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2774668
- GRCh38:
- Chr12:2665502
| CACNA1C | | Timothy syndrome, not provided, Long QT syndrome
| Benign (Jul 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2791820
- GRCh38:
- Chr12:2682654
| CACNA1C-AS1, CACNA1C | E1856A, E1870A, E1898A, E1910A, E1850A, E1858A, E1885A, E1839A, E1867A, E1878A, E1847A, E1869A, E1891A, E1933A | Long qt syndrome 8, Timothy syndrome, Brugada syndrome 3, not provided, Long QT syndrome, Timothy syndrome
| Uncertain significance (Sep 4, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2659147
- GRCh38:
- Chr12:2549981
| CACNA1C | E477K, E474K | Long QT syndrome, Long qt syndrome 8, Timothy syndrome, Brugada syndrome 3 | Uncertain significance (Oct 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2558148
- GRCh38:
- Chr12:2448982
| CACNA1C | V162M | Long qt syndrome 8, Timothy syndrome, Brugada syndrome 3, Long QT syndrome | Uncertain significance (Jun 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2795392
- GRCh38:
- Chr12:2686226
| CACNA1C, CACNA1C-AS1 | I1911S, I1920S, I1962S, I1903S, I1914S, I1922S, I1949S, I1931S, I1933S, I1934S, I1942S, I1955S, I1974S, I1997S | Long qt syndrome 8, Timothy syndrome, Brugada syndrome 3, Long QT syndrome | Uncertain significance (Feb 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2693713
- GRCh38:
- Chr12:2584547
| CACNA1C | A757P, A754P | not provided, Timothy syndrome | Uncertain significance (Nov 1, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2659130
- GRCh38:
- Chr12:2549964
| CACNA1C | T471N, T468N | Timothy syndrome | Uncertain significance (Nov 2, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr12:2694601-2694603
- GRCh38:
- Chr12:2585435-2585437
| CACNA1C | E802del, E799del | Timothy syndrome, Brugada syndrome 3, Long qt syndrome 8, Cardiovascular phenotype, Long QT syndrome | Uncertain significance (Oct 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2224405
- GRCh38:
- Chr12:2115239
| CACNA1C | S22I | Timothy syndrome, Brugada syndrome 3, Long qt syndrome 8, Cardiovascular phenotype, Long QT syndrome | Conflicting interpretations of pathogenicity (Jul 13, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr12:2788743
- GRCh38:
- Chr12:2679577
| CACNA1C, CACNA1C-AS1 | S1742L, S1790L, S1748L, S1750L, S1761L, S1762L, S1770L, S1783L, S1739L, S1731L, S1759L | Long QT syndrome, Timothy syndrome, Cardiovascular phenotype
| Uncertain significance (Jul 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2797829
- GRCh38:
- Chr12:2688663
| CACNA1C, CACNA1C-AS1 | G2001S, G2036S, G2049S, G2061S, G2084S, G2007S, G2018S, G2020S, G1998S, G2009S, G2021S, G2029S, G2042S, G1990S | Cardiovascular phenotype, Timothy syndrome, Brugada syndrome 3, Long QT syndrome | Conflicting interpretations of pathogenicity (May 30, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr12:2715781
- GRCh38:
- Chr12:2606615
| CACNA1C | K1054R, K1074R, K1051R | Timothy syndrome, Brugada syndrome 3, Long qt syndrome 8, Long QT syndrome | Uncertain significance (Jan 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2706426
- GRCh38:
- Chr12:2597260
| CACNA1C | T942A, T939A | Long qt syndrome 8, Timothy syndrome, Brugada syndrome 3, Long QT syndrome, Cardiovascular phenotype | Conflicting interpretations of pathogenicity (Apr 13, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr12:2695026
- GRCh38:
- Chr12:2585860
| CACNA1C | N829S, N826S | Long qt syndrome 8, Timothy syndrome, Brugada syndrome 3, Long QT syndrome, Cardiovascular phenotype | Conflicting interpretations of pathogenicity (Nov 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr12:2690777
- GRCh38:
- Chr12:2581611
| CACNA1C | N639K, N636K | Congenital long QT syndrome, Timothy syndrome, Long QT syndrome
| Uncertain significance (Sep 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2719869
- GRCh38:
- Chr12:2610703
| CACNA1C | | Long qt syndrome 8, Brugada syndrome 3, Timothy syndrome, Long QT syndrome, Cardiovascular phenotype | Uncertain significance (Jan 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2788668
- GRCh38:
- Chr12:2679502
| CACNA1C, CACNA1C-AS1 | A1717V, A1765V, A1714V, A1736V, A1725V, A1734V, A1706V, A1737V, A1745V, A1723V, A1758V | Long QT syndrome, Long qt syndrome 8, Brugada syndrome 3, Timothy syndrome, Long qt syndrome 8, Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures, Brugada syndrome 3, Timothy syndrome, Cardiovascular phenotype
| Conflicting interpretations of pathogenicity (Jun 29, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr12:2795335
- GRCh38:
- Chr12:2686169
| CACNA1C, CACNA1C-AS1 | R1943Q, R1895Q, R1930Q, R1923Q, R1978Q, R1884Q, R1892Q, R1901Q, R1903Q, R1914Q, R1912Q, R1915Q, R1936Q, R1955Q | Long QT syndrome, Long qt syndrome 8, Brugada syndrome 3, Timothy syndrome, Cardiovascular phenotype | Uncertain significance (Jul 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2788893
- GRCh38:
- Chr12:2679727
| CACNA1C, CACNA1C-AS1 | E1792G, E1840G, E1781G, E1809G, E1811G, E1798G, E1812G, E1833G, E1789G, E1800G, E1820G | Long qt syndrome 8, Brugada syndrome 3, Timothy syndrome, Cardiovascular phenotype, Long QT syndrome | Conflicting interpretations of pathogenicity (Aug 16, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr12:2788773
- GRCh38:
- Chr12:2679607
| CACNA1C, CACNA1C-AS1 | T1800I, T1752I, T1760I, T1749I, T1771I, T1780I, T1793I, T1758I, T1769I, T1772I, T1741I | Long QT syndrome, Timothy syndrome | Uncertain significance (Jun 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2788616
- GRCh38:
- Chr12:2679450
| CACNA1C, CACNA1C-AS1 | G1700S, G1748S, G1697S, G1717S, G1689S, G1708S, G1728S, G1706S, G1719S, G1741S, G1720S | not provided, Long QT syndrome, Cardiovascular phenotype, Brugada syndrome 3, Timothy syndrome, not specified
| Conflicting interpretations of pathogenicity (Oct 13, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr12:2675688
- GRCh38:
- Chr12:2566522
| CACNA1C | N537D, N534D | Timothy syndrome, Inborn genetic diseases | Likely pathogenic (Feb 23, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2676818
- GRCh38:
- Chr12:2567652
| CACNA1C | V585M, V582M | not provided, Brugada syndrome 3, Long qt syndrome 8, Timothy syndrome, Long QT syndrome, Cardiovascular phenotype
| Conflicting interpretations of pathogenicity (Nov 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr12:2795379
- GRCh38:
- Chr12:2686213
| CACNA1C, CACNA1C-AS1 | R1910*, R1945*, R1958*, R1907*, R1951*, R1899*, R1918*, R1927*, R1929*, R1930*, R1938*, R1970*, R1916*, R1993* | not provided, Timothy syndrome | Uncertain significance (Jun 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2788953
- GRCh38:
- Chr12:2679787
| CACNA1C, CACNA1C-AS1 | S1812N, S1860N, S1829N, S1801N, S1809N, S1820N, S1832N, S1853N, S1818N, S1831N, S1840N | Timothy syndrome, Inborn genetic diseases, not provided
| Uncertain significance (Sep 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:2711016
- GRCh38:
- Chr12:2601850
| CACNA1C | | Cardiovascular phenotype, Timothy syndrome, Long qt syndrome 8, Brugada syndrome 3, Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures, not provided, Long QT syndrome | Conflicting interpretations of pathogenicity (Jul 11, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr12:2595410
- GRCh38:
- Chr12:2486244
| CACNA1C | N300D | Cardiovascular phenotype, Long qt syndrome 8, Brugada syndrome 3, Timothy syndrome, Long QT syndrome | Conflicting interpretations of pathogenicity (Sep 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr12:2800282
- GRCh38:
- Chr12:2691116
| CACNA1C, CACNA1C-AS1 | E2112Q, E2147Q, E2160Q, E2109Q, E2129Q, E2120Q, E2140Q, E2172Q, E2195Q, E2118Q, E2132Q, E2101Q, E2131Q, E2153Q | Long QT syndrome, Long qt syndrome 8, Brugada syndrome 3, Timothy syndrome | Uncertain significance (Sep 2, 2021) | criteria provided, multiple submitters, no conflicts |